513 related articles for article (PubMed ID: 23706715)
1. Randomized controlled trial of ragweed allergy immunotherapy tablet efficacy and safety in North American adults.
Nolte H; Hébert J; Berman G; Gawchik S; White M; Kaur A; Liu N; Lumry W; Maloney J
Ann Allergy Asthma Immunol; 2013 Jun; 110(6):450-456.e4. PubMed ID: 23706715
[TBL] [Abstract][Full Text] [Related]
2. Randomized controlled trial of a ragweed allergy immunotherapy tablet in North American and European adults.
Creticos PS; Maloney J; Bernstein DI; Casale T; Kaur A; Fisher R; Liu N; Murphy K; Nékám K; Nolte H
J Allergy Clin Immunol; 2013 May; 131(5):1342-9.e6. PubMed ID: 23622121
[TBL] [Abstract][Full Text] [Related]
3. Immunologic effects and tolerability profile of in-season initiation of a standardized-quality grass allergy immunotherapy tablet: a phase III, multicenter, randomized, double-blind, placebo-controlled trial in adults with grass pollen-induced rhinoconjunctivitis.
Reich K; Gessner C; Kroker A; Schwab JA; Pohl W; Villesen H; Wüstenberg E; Emminger W
Clin Ther; 2011 Jul; 33(7):828-40. PubMed ID: 21741092
[TBL] [Abstract][Full Text] [Related]
4. Safety of ragweed sublingual allergy immunotherapy tablets in adults with allergic rhinoconjunctivitis.
Nayak AS; Atiee GJ; Dige E; Maloney J; Nolte H
Allergy Asthma Proc; 2012; 33(5):404-10. PubMed ID: 23026182
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of grass sublingual immunotherapy tablet, MK-7243: a large randomized controlled trial.
Maloney J; Bernstein DI; Nelson H; Creticos P; Hébert J; Noonan M; Skoner D; Zhou Y; Kaur A; Nolte H
Ann Allergy Asthma Immunol; 2014 Feb; 112(2):146-153.e2. PubMed ID: 24468255
[TBL] [Abstract][Full Text] [Related]
6. Treatment of seasonal allergic rhinoconjunctivitis with a once-daily SQ-standardized grass allergy immunotherapy tablet.
Nelson H; Lehmann L; Blaiss MS
Curr Med Res Opin; 2012 Jun; 28(6):1043-51. PubMed ID: 22502864
[TBL] [Abstract][Full Text] [Related]
7. Sublingual immunotherapy in patients with allergic rhinoconjunctivitis caused by ragweed pollen.
Skoner D; Gentile D; Bush R; Fasano MB; McLaughlin A; Esch RE
J Allergy Clin Immunol; 2010 Mar; 125(3):660-6, 666.e1-666.e4. PubMed ID: 20153030
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of a short course of specific immunotherapy in patients with allergic rhinoconjunctivitis to ragweed pollen.
Patel P; Holdich T; Fischer von Weikersthal-Drachenberg KJ; Huber B
J Allergy Clin Immunol; 2014 Jan; 133(1):121-9.e1-2. PubMed ID: 23870670
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and Safety of Ragweed SLIT-Tablet in Children with Allergic Rhinoconjunctivitis in a Randomized, Placebo-Controlled Trial.
Nolte H; Bernstein DI; Nelson HS; Ellis AK; Kleine-Tebbe J; Lu S
J Allergy Clin Immunol Pract; 2020; 8(7):2322-2331.e5. PubMed ID: 32304832
[TBL] [Abstract][Full Text] [Related]
10. Sustained 3-year efficacy of pre- and coseasonal 5-grass-pollen sublingual immunotherapy tablets in patients with grass pollen-induced rhinoconjunctivitis.
Didier A; Worm M; Horak F; Sussman G; de Beaumont O; Le Gall M; Melac M; Malling HJ
J Allergy Clin Immunol; 2011 Sep; 128(3):559-66. PubMed ID: 21802126
[TBL] [Abstract][Full Text] [Related]
11. Canadian trial of sublingual swallow immunotherapy for ragweed rhinoconjunctivitis.
Bowen T; Greenbaum J; Charbonneau Y; Hebert J; Filderman R; Sussman G; Del Carpio J; Gold M; Keith P; Moote W; Cecchetto S; Cecchetto O; Sharp D; Broutin O; André C
Ann Allergy Asthma Immunol; 2004 Nov; 93(5):425-30. PubMed ID: 15562880
[TBL] [Abstract][Full Text] [Related]
12. Randomized, double-blind, placebo-controlled trial of standardized ragweed sublingual-liquid immunotherapy for allergic rhinoconjunctivitis.
Creticos PS; Esch RE; Couroux P; Gentile D; D'Angelo P; Whitlow B; Alexander M; Coyne TC
J Allergy Clin Immunol; 2014 Mar; 133(3):751-8. PubMed ID: 24332263
[TBL] [Abstract][Full Text] [Related]
13. Post-treatment efficacy of discontinuous treatment with 300IR 5-grass pollen sublingual tablet in adults with grass pollen-induced allergic rhinoconjunctivitis.
Didier A; Malling HJ; Worm M; Horak F; Sussman G; Melac M; Soulié S; Zeldin RK
Clin Exp Allergy; 2013 May; 43(5):568-77. PubMed ID: 23600548
[TBL] [Abstract][Full Text] [Related]
14. Immunologic effect and tolerability of intra-seasonal subcutaneous immunotherapy with an 8-day up-dosing schedule to 10,000 standardized quality-units: a double-blind, randomized, placebo-controlled trial.
Pfaar O; Wolf H; Klimek L; Schnitker J; Wüstenberg E
Clin Ther; 2012 Oct; 34(10):2072-81. PubMed ID: 23063373
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of ragweed sublingual immunotherapy in Canadian patients with allergic rhinoconjunctivitis.
Kim H; Waserman S; Hébert J; Blaiss M; Nelson H; Creticos P; Kaur A; Maloney J; Li Z; Nolte H
Allergy Asthma Clin Immunol; 2014; 10(1):55. PubMed ID: 25788949
[TBL] [Abstract][Full Text] [Related]
16. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.
Durham SR; Yang WH; Pedersen MR; Johansen N; Rak S
J Allergy Clin Immunol; 2006 Apr; 117(4):802-9. PubMed ID: 16630937
[TBL] [Abstract][Full Text] [Related]
17. Safety and tolerability of a short ragweed sublingual immunotherapy tablet.
Nolte H; Amar N; Bernstein DI; Lanier BQ; Creticos P; Berman G; Kaur A; Hébert J; Maloney J
Ann Allergy Asthma Immunol; 2014 Jul; 113(1):93-100.e3. PubMed ID: 24836393
[TBL] [Abstract][Full Text] [Related]
18. A phase 3 trial assessing the efficacy and safety of grass allergy immunotherapy tablet in subjects with grass pollen-induced allergic rhinitis with or without conjunctivitis, with or without asthma.
Murphy K; Gawchik S; Bernstein D; Andersen J; Pedersen MR
J Negat Results Biomed; 2013 Jun; 12():10. PubMed ID: 23725348
[TBL] [Abstract][Full Text] [Related]
19. Allergy immunotherapy tablet: Grazax® for the treatment of grass pollen allergy.
Senna GE; Calderon M; Milani M
Expert Rev Clin Immunol; 2011 Jan; 7(1):21-7. PubMed ID: 21162646
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis.
Frew AJ; Powell RJ; Corrigan CJ; Durham SR;
J Allergy Clin Immunol; 2006 Feb; 117(2):319-25. PubMed ID: 16461133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
